Smoldering Multiple Myeloma

specific

A very slow-growing type of myeloma in which abnormal plasma cells (a type of white blood cell) make too much of a single type of monoclonal antibody (a protein). This protein builds up in the blood or is passed in the urine. Patients with smoldering myeloma usually have no symptoms, but need to be checked often for signs of progression to fully developed multiple myeloma.

57

Centers

119

Active Trials

$8M

Cancer Funding

Top Centers for Smoldering Multiple Myeloma(57)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
81.5
2
High-Volume Research Center
79.6
3
NCI Comprehensive
High-Volume Research Center
71.8
4
High-Volume Research Center
70.6
5
High-Volume Research Center
70.6
6
NCI Comprehensive
Active Research Program
68.2
768.2
8
NCI Clinical
Active Research Program
68.2
9
Active Research Program
68.2
10
NCI Comprehensive
Active Research Program
63.1
11
NCI Comprehensive
Active Research Program
63.1
12
NCI Comprehensive
Active Research Program
63.1
13
Active Research Program
63.1
14
Active Research Program
63.1
15
NCI Comprehensive
Active Research Program
63.1
16
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
63.1
17
NCI Comprehensive
Active Research Program
55.2
18
NCI Comprehensive
Active Research Program
54.6
19
NCI Comprehensive
Active Research Program
53.2
20
NCI Comprehensive
Active Research Program
53.2
21
NCI Comprehensive
Active Research Program
53.2
22
NCI Comprehensive
Active Research Program
53.2
23
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
53.2
24
NCI Comprehensive
Active Research Program
53.2
25
NCI Comprehensive
Active Research Program
53.2
26
NCI Clinical
Active Research Program
53.2
27
NCI Comprehensive
Active Research Program
53.2
28
NCI Comprehensive
Active Research Program
53.2
29
Active Research Program
53.2
30
Active Research Program
53.2
31
Active Research Program
53.2
32
Active Research Program
53.2
33
Active Research Program
53.2
34
Active Research Program
53.2
35
NCI Comprehensive
Active Research Program
37.4
36
NCI Comprehensive
Active Research Program
37.4
37
NCI Comprehensive
Active Research Program
37.4
38
NCI Comprehensive
Active Research Program
37.4
39
NCI Comprehensive
Active Research Program
37.4
40
NCI Comprehensive
Active Research Program
37.4
41
NCI Comprehensive
Active Research Program
37.4
42
NCI Clinical
Active Research Program
37.4
43
NCI Comprehensive
Active Research Program
37.4
44
NCI Comprehensive
Active Research Program
37.4
45
NCI Comprehensive
Active Research Program
37.4
46
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
37.4
47
NCI Comprehensive
Active Research Program
37.4
48
Active Research Program
37.4
49
NCI Comprehensive
Active Research Program
37.4
50
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
37.4
5137.4
52
Active Research Program
37.4
53
NCI Basic_laboratory
Active Research Program
37.4
5437.4
55
Active Research Program
37.4
56
Active Research Program
37.4
57
NCI Comprehensive
27.5

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →